Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$473,908
-$175,080 QoQ
Shares Held
1,866
-29.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#3,745
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Voya Financial Advisors, Inc. holds $8,834,039 across 10 Drug Manufacturers - General names. JNJ ranks #8 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GSK |
GSK plc
|
31,519 | $1,652,225 | |
| 2 | NVS |
Novartis AG
|
10,020 | $1,570,334 | |
| 3 | AMGN |
Amgen Inc
|
3,137 | $1,135,970 | |
| 4 | LLY |
ELI LILLY & Co
|
805 | $965,541 | |
| 5 | ABBV |
AbbVie Inc.
|
3,390 | $853,059 | |
| 6 | PFE |
Pfizer Inc
|
34,853 | $839,260 | |
| 7 | SNY |
Sanofi
|
14,392 | $613,962 | |
| 8 | JNJ |
Johnson & Johnson
This page
|
1,866 | $473,908 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $473,908 | 1,866 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $648,988 | 2,655 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $654,789 | 3,164 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $717,019 | 3,867 | Shares | Defined | 2025-10-09 | |
| 2025-06-30 | $705,399 | 4,618 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $802,499 | 4,839 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $722,810 | 4,998 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $764,274 | 4,716 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $667,512 | 4,567 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $678,951 | 4,292 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $686,207 | 4,378 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $725,795 | 4,660 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,622,592 | 9,803 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,522,410 | 9,822 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,078,817 | 11,768 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,039,876 | 12,487 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,216,034 | 12,484 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,878,638 | 10,600 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,456,489 | 8,514 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,394,875 | 8,637 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,387,605 | 8,423 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $11,871,493 | 72,233 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $11,360,003 | 72,182 | Shares | Defined | 2021-03-05 | |
| 2020-09-30 | $10,790,375 | 72,477 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $10,563,984 | 75,119 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $10,059,113 | 76,711 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||